Randall Shultz's most recent trade in Arcadia Biosciences Inc was a trade of 55,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 21, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Arcadia Biosciences Inc | Randall Shultz | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2021 | 55,000 | 115,000 | - | - | Stock Option (right to buy) | |
Arcadia Biosciences Inc | Randall Shultz | Chief Technology Officer | Purchase of securities on an exchange or from another person at price $ 3.16 per share. | 21 Jan 2021 | 700 | 13,000 (0%) | 0% | 3.2 | 2,212 | Common Stock |
Arcadia Biosciences Inc | Randall Shultz | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2020 | 18,000 | 60,000 | - | - | Stock Option (Right to Buy) |